Skip to main content
Livermore
Livermore
ZHEN

Fox Run Management, L.L.C.

SEC CIK
0001533457
Latest filing
Aug 4, 2026

ACAD holding history

Acadia Pharmaceuticals Inc in every 13F filed by Fox Run Management, L.L.C., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACAD overviewAll 13F holders of ACADFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
12
Since Q2 2021
Holdings of ACAD by Fox Run Management, L.L.C., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−21,666−100.0%Sold outHolders
Q1 202621,666$456.5K0.1%+11,114+105.3%AddedHolders
Q4 202510,552$281.8K<0.1%+10,552NewHolders
Q2 20250$00.0%−31,938−100.0%Sold outHolders
Q1 202531,938$530.5K0.1%+6,516+25.6%AddedHolders
Q4 202425,422$466.5K0.1%+25,422NewHolders
Q3 20240$00.0%−20,302−100.0%Sold outHolders
Q2 202420,302$329.9K0.1%+20,302NewHolders
Q4 20230$00.0%−23,477−100.0%Sold outHolders
Q3 202323,477$489.3K0.1%+23,477NewHolders
Q2 20230$00.0%−63,707−100.0%Sold outHolders
Q1 202363,707$1.20M0.4%+63,707NewHolders
Q4 20220$00.0%−14,920−100.0%Sold outHolders
Q3 202214,920$244.0K0.1%+4,843+48.1%AddedHolders
Q2 202210,077$142.0K0.1%−14,023−58.2%ReducedHolders
Q1 202224,100$584.0K0.3%+24,100NewHolders
Q4 20210$00.0%−12,027−100.0%Sold outHolders
Q3 202112,027$200.0K0.1%−950−7.3%ReducedHolders
Q2 202112,977$317.0K0.3%+12,977NewHolders